Christopher Patusky United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

Christopher Patusky is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 900 shares of UTHR, which is worth approximately $308,331. The most recent transaction as insider was on May 17, 2022, when has been sold 2,000 shares (Common Stock) at a price of $63.9 per share, resulting in proceeds of $127,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 900
Infinity% 3M change
46.56% 12M change
Total Value Held $308,331

CHRISTOPHER PATUSKY Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2022
BUY
Exercise of conversion of derivative security
$127,800 $63.9 p/Share
2,000 Added 35.21%
3,680 Common Stock
Apr 07 2022
SELL
Sale (or disposition) back to the issuer
$380,220 $190.11 p/Share
2,000 Reduced 54.35%
1,680 Common Stock
Apr 07 2022
BUY
Exercise of conversion of derivative security
$127,800 $63.9 p/Share
2,000 Added 35.21%
3,680 Common Stock
Mar 15 2022
SELL
Sale (or disposition) back to the issuer
$357,640 $178.82 p/Share
2,000 Reduced 54.35%
1,680 Common Stock
Mar 15 2022
BUY
Exercise of conversion of derivative security
$176,060 $88.03 p/Share
2,000 Added 35.21%
3,680 Common Stock
Nov 11 2021
SELL
Sale (or disposition) back to the issuer
$401,800 $200.9 p/Share
2,000 Reduced 54.35%
1,680 Common Stock
Nov 11 2021
BUY
Exercise of conversion of derivative security
$127,800 $63.9 p/Share
2,000 Added 35.21%
3,680 Common Stock
Nov 08 2021
SELL
Open market or private sale
$460,368 $200.16 p/Share
2,300 Reduced 57.79%
1,680 Common Stock
Aug 04 2021
SELL
Sale (or disposition) back to the issuer
$412,180 $206.09 p/Share
2,000 Reduced 33.44%
3,980 Common Stock
Aug 04 2021
BUY
Exercise of conversion of derivative security
$127,800 $63.9 p/Share
2,000 Added 25.06%
5,980 Common Stock
Jun 26 2021
BUY
Exercise of conversion of derivative security
-
1,680 Added 29.68%
3,980 Common Stock
May 06 2021
SELL
Sale (or disposition) back to the issuer
$480,175 $192.07 p/Share
2,500 Reduced 52.08%
2,300 Common Stock
May 06 2021
BUY
Exercise of conversion of derivative security
$159,750 $63.9 p/Share
2,500 Added 34.25%
4,800 Common Stock
Dec 08 2020
SELL
Sale (or disposition) back to the issuer
$405,240 $135.08 p/Share
3,000 Reduced 56.6%
2,300 Common Stock
Dec 08 2020
BUY
Exercise of conversion of derivative security
$191,700 $63.9 p/Share
3,000 Added 36.14%
5,300 Common Stock
Jun 10 2019
BUY
Open market or private purchase
$331 $82.83 p/Share
4 Added 0.24%
1,684 Common Stock
Dec 28 2018
SELL
Open market or private sale
$420 $105.11 p/Share
4 Reduced 0.24%
1,680 Common Stock
May 21 2018
SELL
Open market or private sale
$208 $104.12 p/Share
2 Reduced 0.12%
1,684 Common Stock
Apr 20 2018
BUY
Open market or private purchase
$684 $114.06 p/Share
6 Added 0.35%
1,686 Common Stock
Mar 20 2018
SELL
Open market or private sale
$538 $107.71 p/Share
5 Reduced 0.3%
1,680 Common Stock
Nov 20 2017
BUY
Open market or private purchase
$631 $126.2 p/Share
5 Added 0.3%
1,685 Common Stock
Oct 20 2017
SELL
Open market or private sale
$726 $121.01 p/Share
6 Reduced 0.36%
1,680 Common Stock
Jul 28 2017
BUY
Open market or private purchase
$385 $128.35 p/Share
3 Added 0.18%
1,686 Common Stock
Jul 17 2017
BUY
Open market or private purchase
$390 $130.24 p/Share
3 Added 0.18%
1,683 Common Stock
CP

Christopher Patusky

Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR